165 related articles for article (PubMed ID: 9795766)
1. Myelin protein expression in lymphoid tissues: implications for peripheral tolerance.
Voskuhl RR
Immunol Rev; 1998 Aug; 164():81-92. PubMed ID: 9795766
[TBL] [Abstract][Full Text] [Related]
2. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
3. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
[TBL] [Abstract][Full Text] [Related]
4. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD
J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718
[TBL] [Abstract][Full Text] [Related]
5. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
6. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
7. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
9. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
Bebo BF; Vandenbark AA; Offner H
J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
[TBL] [Abstract][Full Text] [Related]
10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Kuerten S; Schickel A; Kerkloh C; Recks MS; Addicks K; Ruddle NH; Lehmann PV
Acta Neuropathol; 2012 Dec; 124(6):861-73. PubMed ID: 22842876
[TBL] [Abstract][Full Text] [Related]
12. T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis.
Perry LL; Barzaga-Gilbert E; Trotter JL
J Neuroimmunol; 1991 Jul; 33(1):7-15. PubMed ID: 1711539
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
[TBL] [Abstract][Full Text] [Related]
14. The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra- and intermolecular dominant epitopes.
Zhao ML; Fritz RB
J Neuroimmunol; 1995 Sep; 61(2):179-84. PubMed ID: 7593553
[TBL] [Abstract][Full Text] [Related]
15. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
[TBL] [Abstract][Full Text] [Related]
16. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis.
MacKenzie-Graham AJ; Pribyl TM; Kim S; Porter VR; Campagnoni AT; Voskuhl RR
J Immunol; 1997 Nov; 159(9):4602-10. PubMed ID: 9379062
[TBL] [Abstract][Full Text] [Related]
17. The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
Vanderlugt CL; Begolka WS; Neville KL; Katz-Levy Y; Howard LM; Eagar TN; Bluestone JA; Miller SD
Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764
[TBL] [Abstract][Full Text] [Related]
18. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
[TBL] [Abstract][Full Text] [Related]
19. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
[TBL] [Abstract][Full Text] [Related]
20. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB
Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
